Koyfin Home > Directory > Health Care > Adamas Pharma > Net Debt / (EBITDA-CAPEX)

Adamas Pharma Net Debt / (EBITDA-CAPEX) Chart (ADMS)

Adamas Pharma annual/quarterly Net Debt / (EBITDA-CAPEX) from 2012 to 2020.
  • Adamas Pharma Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $-1m a 114.18% decrease of -1m year over year
  • Adamas Pharma Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $-1m a 127.76% decrease of -1m year over year
  • Adamas Pharma Annual Net Debt / (EBITDA-CAPEX) for 2019 was $0m a 1,475.75% decrease of -1m from 2018
  • Adamas Pharma Annual Net Debt / (EBITDA-CAPEX) for 2018 was $1m a -0.48% decrease of 0m from 2017
  • Adamas Pharma Annual Net Debt / (EBITDA-CAPEX) for 2017 was $1m a -128.66% decrease of -1m from 2016
Other Ratios Metrics:
  • Adamas Pharma Total Debt / Capital for the quarter ending September 09, 2018 was $50m a -21.13% decrease of -11m year over year
  • Adamas Pharma Other Liabilities for the quarter ending December 12, 2018 was $3m a 76.22% increase of 2m year over year
  • Adamas Pharma Total Debt / Equity for the quarter ending September 09, 2018 was $101m a -53.94% decrease of -54m year over year
View Chart On Koyfin

Quarterly ADMS Net Debt / (EBITDA-CAPEX) Data

06/2020$-1m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$0m
03/2019$1m
12/2018$1m
09/2018$1m
06/2018$1m
03/2018$1m

Annual ADMS Net Debt / (EBITDA-CAPEX) Data

2019$0m
2018$1m
2017$1m
2016$2m
2015$2m
2014$-7m
2013$-2m
2012$-3m
2011$0m